Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,009 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Trial Evaluating the Immunogenicity and Safety of an Adjuvanted Epstein-Barr Virus (EBV) Glycoprotein 350 Vaccine in EBV-seronegative Persons

NCT05683834

Conditions: DNA Virus Infections, Epstein-Barr Virus Infection, Epstein-Barr Virus Infections, +18 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Completed

Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)

NCT02433795

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Chonbuk National University Hospital Jeonju, Jeollabuk-do, South Korea

Hallym University Medical Center Anyang-si, South Korea

Chungnam National University Daejeon, South Korea

Gachon University Gil Medical Center Incheon, South Korea

View Trial Details

Completed

Safety of Clofarabine With Multiagent Chemotherapy in Childhood Acute Lymphoblastic Leukemia

NCT01279096

Conditions: Acute Lymphoid Leukemia Relapse, Acute Lymphoid Leukemia Relapse After Bone Marrow Transplant, Disease Attributes, +14 more
Locations: Besançon University Hospital Besançon, France

Lille University Hospital Lille, France

View Trial Details

Completed

Acalabrutinib With Bendamustine / Rituximab Followed by Cytarabine / Rituximab for Untreated Mantle Cell Lymphoma

NCT03623373

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Completed

Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)

NCT03213678

Conditions: Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, +82 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

Providence Alaska Medical Center Anchorage, Alaska, United States

Banner Children's at Desert Mesa, Arizona, United States

Banner University Medical Center - Tucson Tucson, Arizona, United States

View all 127 locations

View Trial Details

Completed

Positive Youth Development in the Metaverse

NCT05858593

Conditions: Behavior, Behavior, Child, Child Behavior, +14 more
Locations: Athens Chess & Community Athens, Georgia, United States

View Trial Details

Completed

Cholecalciferol in Newly Diagnosed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia With Vitamin D Deficiency

NCT02553447

Conditions: Avitaminosis, Chronic Disease, Chronic Lymphocytic Leukemia, +24 more
Locations: University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy

NCT03595813

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, +17 more
Locations: Institut Paoli-Calmettes Marseille, Bouches-du-Rhône, France

View Trial Details

Completed

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT01816971

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Dana Farber Boston, Massachusetts, United States

Washington University in St Louis St Louis, Missouri, United States

Sarah Cannon Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

The Myeloma Pack: A Multi-Modality Educational Intervention Strategy to Engage Patients With Multiple Myeloma

NCT03777306

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions